Literature DB >> 8855296

Human cytomegalovirus inhibits antigen presentation by a sequential multistep process.

K Ahn1, A Angulo, P Ghazal, P A Peterson, Y Yang, K Früh.   

Abstract

The human cytomegalovirus (HCMV) genomic unique short (US) region encodes a family of homologous genes essential for the inhibition of major histocompatibility complex (MHC) class I-mediated antigen presentation during viral infection. Here we show that US3, the only immediate early (IE) gene within the US region, encodes an endoplasmic reticulum-resident glycoprotein that prevents intracellular transport of MHC class I molecules. In contrast to the rapid degradation of newly synthesized MHC class I heavy chains mediated by the early gene product US11, we found that US3 retains stable MHC class I heterodimers in the endoplasmic reticulum that are loaded with peptides while retained in the ER. Consistent with the expression pattern of US3 and US11, MHC class I molecules are retained but not degraded during the IE period of infection. Our data identify the first nonregulatory role of an IE protein of HCMV and suggest that HCMV uses different T-cell escape strategies at different times during the infectious cycle.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8855296      PMCID: PMC38271          DOI: 10.1073/pnas.93.20.10990

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  38 in total

Review 1.  Monoclonal antibodies for analysis of the HLA system.

Authors:  F M Brodsky; P Parham; C J Barnstable; M J Crumpton; W F Bodmer
Journal:  Immunol Rev       Date:  1979       Impact factor: 12.988

2.  The human cytomegalovirus US11 gene product dislocates MHC class I heavy chains from the endoplasmic reticulum to the cytosol.

Authors:  E J Wiertz; T R Jones; L Sun; M Bogyo; H J Geuze; H L Ploegh
Journal:  Cell       Date:  1996-03-08       Impact factor: 41.582

Review 3.  Generation, translocation, and presentation of MHC class I-restricted peptides.

Authors:  M T Heemels; H Ploegh
Journal:  Annu Rev Biochem       Date:  1995       Impact factor: 23.643

4.  In vivo assembly of the proteasomal complexes, implications for antigen processing.

Authors:  Y Yang; K Früh; K Ahn; P A Peterson
Journal:  J Biol Chem       Date:  1995-11-17       Impact factor: 5.157

5.  Cytokines restore MHC class I complex formation and control antigen presentation in human cytomegalovirus-infected cells.

Authors:  H Hengel; C Esslinger; J Pool; E Goulmy; U H Koszinowski
Journal:  J Gen Virol       Date:  1995-12       Impact factor: 3.891

6.  Herpes simplex virus turns off the TAP to evade host immunity.

Authors:  A Hill; P Jugovic; I York; G Russ; J Bennink; J Yewdell; H Ploegh; D Johnson
Journal:  Nature       Date:  1995-06-01       Impact factor: 49.962

7.  Multiple independent loci within the human cytomegalovirus unique short region down-regulate expression of major histocompatibility complex class I heavy chains.

Authors:  T R Jones; L K Hanson; L Sun; J S Slater; R M Stenberg; A E Campbell
Journal:  J Virol       Date:  1995-08       Impact factor: 5.103

8.  Retinoid activation of retinoic acid receptors but not of retinoid X receptors promotes cellular differentiation and replication of human cytomegalovirus in embryonal cells.

Authors:  A Angulo; C Suto; M F Boehm; R A Heyman; P Ghazal
Journal:  J Virol       Date:  1995-06       Impact factor: 5.103

9.  Assembly of ER-associated protein degradation in vitro: dependence on cytosol, calnexin, and ATP.

Authors:  A A McCracken; J L Brodsky
Journal:  J Cell Biol       Date:  1996-02       Impact factor: 10.539

10.  Activation of transcription factor NF-kappaB by the adenovirus E3/19K protein requires its ER retention.

Authors:  H L Pahl; M Sester; H G Burgert; P A Baeuerle
Journal:  J Cell Biol       Date:  1996-02       Impact factor: 10.539

View more
  116 in total

1.  A cytomegalovirus glycoprotein re-routes MHC class I complexes to lysosomes for degradation.

Authors:  U Reusch; W Muranyi; P Lucin; H G Burgert; H Hengel; U H Koszinowski
Journal:  EMBO J       Date:  1999-02-15       Impact factor: 11.598

2.  Structural and functional dissection of human cytomegalovirus US3 in binding major histocompatibility complex class I molecules.

Authors:  S Lee; J Yoon; B Park; Y Jun; M Jin; H C Sung; I H Kim; S Kang; E J Choi; B Y Ahn; K Ahn
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

3.  Macrophages escape inhibition of major histocompatibility complex class I-dependent antigen presentation by cytomegalovirus.

Authors:  H Hengel; U Reusch; G Geginat; R Holtappels; T Ruppert; E Hellebrand; U H Koszinowski
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

Review 4.  Lessons from viral manipulation of protein disposal pathways.

Authors:  Margo H Furman; Hidde L Ploegh
Journal:  J Clin Invest       Date:  2002-10       Impact factor: 14.808

5.  MHC class I-subversive gene functions of cytomegalovirus and their regulation by interferons-an intricate balance.

Authors:  C Benz; H Hengel
Journal:  Virus Genes       Date:  2000       Impact factor: 2.332

Review 6.  The MHC class I antigen presentation pathway: strategies for viral immune evasion.

Authors:  Eric W Hewitt
Journal:  Immunology       Date:  2003-10       Impact factor: 7.397

7.  Characterization of the human cytomegalovirus UL34 gene.

Authors:  B J Biegalke; E Lester; A Branda; R Rana
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

Review 8.  Virus subversion of protective immunity.

Authors:  Eric W Hewitt; Gillian E Dugan
Journal:  Curr Allergy Asthma Rep       Date:  2004-09       Impact factor: 4.806

9.  Bone-marrow-derived mesenchymal stem cells as a target for cytomegalovirus infection: implications for hematopoiesis, self-renewal and differentiation potential.

Authors:  Sergey V Smirnov; Ryhor Harbacheuski; Anita Lewis-Antes; Hua Zhu; Pranela Rameshwar; Sergei V Kotenko
Journal:  Virology       Date:  2006-11-17       Impact factor: 3.616

10.  Human cytomegalovirus UL83-coded pp65 virion protein inhibits antiviral gene expression in infected cells.

Authors:  Edward P Browne; Thomas Shenk
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-12       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.